NEW YORK (GenomeWeb News) — Sequenom today said it has licensed Isis Innovation’s intellectual property for non-invasive prenatal genetic testing.
 
Under the agreement, Sequenom licensed rights for Isis’s non-invasive prenatal diagnostic testing on nucleic acids derived from maternal plasma or serum, the company said.
 
Isis is Oxford University’s technology transfer company. It works to develop and market commercial applications for intellectual property owned by the school.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.